Testing effectiveness (Phase 2)Ended earlyNCT03679624
What this trial is testing
Daratumumab Plus Ibrutinib in Patients With Waldenstrӧm's Macroglobulinemia
Who this might be right for
Waldenstrom MacroglobulinemiaWaldenstrom's DiseaseWaldenström; Hypergammaglobulinemia+4 more
Weill Medical College of Cornell University 1